Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey

被引:72
作者
Barriere, J. [1 ]
Gal, J. [2 ]
Hoch, B. [3 ]
Cassuto, O. [4 ]
Leysalle, A. [1 ]
Chamorey, E. [2 ]
Borchiellini, D. [5 ]
机构
[1] Clin St Jean, Dept Med Oncol, Cagnes Sur Mer, France
[2] Ctr Antoine Lacassagne, Dept Biostat & Epidemiol, Nice, France
[3] Ctr Azureen Cancerol, Dept Med Oncol, Mougins, France
[4] Clin St George, Dept Med Oncol, Nice, France
[5] Ctr Antoine Lacassagne, Dept Med Oncol, Nice, France
关键词
CHEMOTHERAPY;
D O I
10.1016/j.annonc.2021.01.066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:673 / 674
页数:2
相关论文
共 5 条
  • [1] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
    Anderson, E. J.
    Rouphael, N. G.
    Widge, A. T.
    Jackson, L. A.
    Roberts, P. C.
    Makhene, M.
    Chappell, J. D.
    Denison, M. R.
    Stevens, L. J.
    Pruijssers, A. J.
    McDermott, A. B.
    Flach, B.
    Lin, B. C.
    Doria-Rose, N. A.
    O'Dell, S.
    Schmidt, S. D.
    Corbett, K. S.
    Swanson, P. A., II
    Padilla, M.
    Neuzil, K. M.
    Bennett, H.
    Leav, B.
    Makowski, M.
    Albert, J.
    Cross, K.
    Edara, V. V.
    Floyd, K.
    Suthar, M. S.
    Martinez, D. R.
    Baric, R.
    Buchanan, W.
    Luke, C. J.
    Phadke, V. K.
    Rostad, C. A.
    Ledgerwood, J. E.
    Graham, B. S.
    Beigel, J. H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) : 2427 - 2438
  • [2] COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
    Lee, Lennard Y. W.
    Cozier, Jean-Baptiste
    Starkey, Thomas
    Briggs, Sarah E. W.
    Arnold, Roland
    Bisht, Vartika
    Booth, Stephen
    Campton, Naomi A.
    Cheng, Vinton W. T.
    Collins, Graham
    Curley, Helen M.
    Earwaker, Philip
    Fittall, Matthew W.
    Gennatas, Spyridon
    Goel, Anshita
    Hartley, Simon
    Hughes, Daniel J.
    Kerr, David
    Lee, Alvin J. X.
    Lee, Rebecca J.
    Lee, Siow Ming
    Mckenzie, Hayley
    Middleton, Chris P.
    Murugaesu, Nirupa
    Newsom-Davis, Tom
    Olsson-Brown, Anna C.
    Palles, Claire
    Powles, Thomas
    Protheroe, Emily A.
    Purshouse, Karin
    Sharma-Oates, Archana
    Sivakumar, Shivan
    Smith, Ashley J.
    Topping, Oliver
    Turnbull, Chris D.
    Varnai, Csilla
    Briggs, Adam D. M.
    Middletont, Gary
    Kerr, Rachel
    [J]. LANCET ONCOLOGY, 2020, 21 (10) : 1309 - 1316
  • [3] Response to influenza virus vaccination during chemotherapy in patients with breast cancer
    Meerveld-Eggink, A.
    de Weerdt, O.
    van der Velden, A. M. T.
    Los, M.
    van der Velden, A. W. G.
    Stouthard, J. M. L.
    Nijziel, M. R.
    Westerman, M.
    Beeker, A.
    van Beek, R.
    Rimmelzwaan, G. F.
    Rijkers, G. T.
    Biesma, D. H.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (09) : 2031 - 2035
  • [4] Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
    Rousseau, B.
    Loulergue, P.
    Mir, O.
    Krivine, A.
    Kotti, S.
    Viel, E.
    Simon, T.
    de Gramont, A.
    Goldwasser, F.
    Launay, O.
    Tournigand, C.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (02) : 450 - 457
  • [5] Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
    Yri, Olav Erich
    Torfoss, Dag
    Hungnes, Olav
    Tierens, Anne
    Waalen, Kristian
    Nordoy, Tone
    Dudman, Susanne
    Kilander, Anette
    Wader, Karin Fahl
    Ostenstad, Bjorn
    Ekanger, Roald
    Meyer, Peter
    Kolstad, Arne
    [J]. BLOOD, 2011, 118 (26) : 6769 - 6771